Perfusion Systems Market Is Likely To Up Demand At A USD 1.55 Billion By 2030


 San Francisco, 29 Aug 2024: The Report Perfusion Systems Market Size, Share & Trends Analysis Report By Application (Cardiopulmonary Perfusion System, Cell Perfusion System), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030

The global perfusion systems market size is projected to reach USD 1.55 billion by 2030, according to a new report by Grand View Research, Inc. Furthermore, the market is projected to advance at a CAGR of 4.8% from 2024 to 2030. Factors such as the growing prevalence of chronic diseases and the rise in the number of organ transplants and multiple organ failures are anticipated to boost the market growth. In addition, increasing investments in cell-based research and a rise in biologics manufacturing are further expected to impel the growth of the perfusion system industry.

There was a steep downfall in the sales of perfusion systems during the first half of the pandemic. The lockdowns and restrictions imposed by governments globally resulted in reduced patient visits to hospitals, a reduced number of surgeries, and a slowdown in R&D activities. However, with the increasing efforts of the government and healthcare professionals to curb the spread of the virus and prepare for similar events in the future, the market began to recover in 2021 and is expected to flourish during the forecast period.

Access Research Report of Perfusion Systems Market https://www.grandviewresearch.com/industry-analysis/perfusion-system-market

Perfusion Systems Market Report Highlights

  • Based on application, the perfusion systems market is segmented into cardiopulmonary perfusion system, cell perfusion system, and ex-vivo organ perfusion system. The cardiopulmonary perfusion system dominated the market in 2023 due to the high prevalence of cardiac diseases globally
  • In terms of region, North America accounted for the highest market share in 2023. The rising incidences of chronic disorders, a well-established healthcare sector, and a rise in the number of organ donors are driving the regional market growth
  • The COVID-19 pandemic had a significant negative impact on the market for perfusion systems. Factors such as the change in healthcare priorities, social distancing, and global lockdowns resulted in a reduced number of surgeries and a fall in the number of organ donations and transplants
  • The coronavirus outbreak led to a decline in the sales of perfusion systems; however, post the first wave of the pandemic, the market recovered and is expected to reach its pre-COVID growth level during the forecast period

Perfusion Systems Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 1.17 billion

Revenue forecast in 2030

USD 1.55 billion

Growth rate

CAGR of 4.8% from 2024 to 2030

Actual data

2018 - 2023

Forecast period

2024 - 2030

List Of Key Players in the Perfusion Systems Market

  • Getinge
  • Medtronic, plc
  • LivaNova PLC
  • Terumo Corporation
  • Nipro Corporation
  • Fresenius SE & Co. KGaA (XENIOS AG)
  • Repligen Corporation
  • Spectrum Medical
  • Merck KGaA
  • Harvard Bioscience, Inc.
  • Lifeline Scientific
  • ALA Scientific Instruments, Inc.
  • XVIVO Perfusion AB

Access Press Release of Perfusion Systems Market @ https://www.grandviewresearch.com/press-release/global-perfusion-system-market

About Grand View Research

Grand View Research is an India & U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For More Information: https://www.grandviewresearch.com/horizon

Comments

Popular posts from this blog

Asia Pacific PoC Diagnostics Market Growth Opportunities, Industry Analysis And Forecast: Grand View Research Inc.

U.K. Point Of Sale Software Market To Expand Industry Growth At USD 1.05 Billion By 2028